Table 1.
Statistical Summary of the Pre, During, and Post LP
| Measurement (during LP) | N | (R1) | (R2) | p value |
|---|---|---|---|---|
| Compliancea (mL/mmHg) | n = 15 | 0.70 ± 0.34 (range 0.28–1.5) | 3.39 ± 1.84 (range 1.05–7.69) | < 0.0001 |
| Measurement (pre/post LP) | N | Pre-LP | Post-LP | p value |
|---|---|---|---|---|
| CSFP (mmHg) | n = 18 | 33.11 ± 5.78 (range 20–42) | 13.73 ± 2.44 (range 10–17) | < 0.0001 |
| CPA (mmHg) | n = 12 | 8.08 ± 2.48 (range 4.37–13.66) | 1.29 ± 0.64 (range 0.54–2.29) | < 0.0001 |
| CPP (mmHg) | n = 18 | 53.22 ± 14.45 (range 30–87) | 72.33 ± 10.58 (range 59–103) | < 0.0001 |
aOnly subjects with two compliance regions identified by Joinpoint were used in the mean calculation